Respiratory clinicians and researchers are joining forces at the 10th annual Newcastle Asthma Meeting (NAMe10) this week to highlight the latest clinical interventions and important areas of experimental research in asthma and COPD.
There is a strong focus on the translation of cutting-edge respiratory science into clinical application, according to meeting convenor Professor Phil Hansbro*, from the University of Newcastle.
“We’re bringing together basic scientists and clinicians from some of the premier asthma and respiratory research groups in Australia, New Zealand and internationally to foster collaborations between these groups,” Professor Hansbro said.
“The ultimate goal is to develop the best management strategies and to identify, develop and test novel treatments and cures for asthma, COPD and other airways diseases.”
Among the international guest speakers are Professor Marsha Wills-Karp from Johns Hopkins University in Baltimore, who will discuss immune modulation for asthma and how novel “monoclonals” (cells produced from a single parent cell) will change the face of asthma management.
Professor Thomas Murry from New York’s Weill Cornell Medical College is presenting on chronic cough, which affects 16 per cent of the world’s population and is the leading cause of GP visits.
Other international speakers are Professor Ian Adcock from London’s Imperial College and National Heart & Lung Foundation, and Canadian researcher Dr Jeremy Hirota from James Hogg Research Centre in Vancouver.
Along with Dr Alison Thorburn, Professor Phil Hansbro will reveal how diet and gut bacteria influence chronic respiratory disease, as featured recently on ABC’s Catalyst program.
NAMe10 is being held at the HMRI Building on October 23-24. A lead-in workshop for GPs, clinicians and primary carers from the health industry was held yesterday.
*HMRI is a partnership between the University of Newcastle, Hunter New England Health and the community.